Smart invasome synthesis, characterizations, pharmaceutical applications, and pharmacokinetic perspective: a review

Sopan Nangare1, Shailesh Dugam2
1Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule, MS, 425405, India
2Institute of Chemical Technology, Matunga, Mumbai, MS, 400019, India

Tóm tắt

Abstract Background Scientists are constantly looking for the introduction of unique drug delivery systems for the existing drug molecule. Since the skin is one of the primary and essential organs of the human body, it needs successful research development for the delivery of the drug. While the skin is assumed a human body’s multifunctional organ, it has minimal permeability across the stratum corneum (SC). Since this is an influential barrier for the active agent, several carrier platforms to surmount this obstacle have been created. Invasomes are the liposomal vesicles, which incorporate small quantities of ethanol and terpenes or a mixture of terpenes, as potentials for improved penetration of the skin. The rate of penetration of invasomes through the skin is significantly greater than that of liposomes and ethosomes. Invasomes focus on providing a series of benefits namely enhanced drug effectiveness, increased conformity, and ease for patients. Main body The present article portrays insights of invasomes which include composition and preparation methods of invasomes. The article gives a brief review of the penetration mechanism, synthesis process, and characterizations of invasomes. The article gives a point by point audit about pharmaceutical applications, viz. anticancer, antihypertensive, anti-acne, vitamin analog, anticholinergic, antioxidant, etc. The pharmacokinetic properties of invasomes have also been described. Conclusion The key goal of an invasome-based delivery system is not only to strengthen the efficacy and safety of the drug but also to dramatically increase patient conformity and the therapeutic value to a significant extent. The delivery of drugs via the skin membrane in advanced drug delivery systems is a fascinating fact. Many pharmaceutical studies have shown that plentiful drug molecules are less soluble, have less bioavailability and stability, have less penetration, etc. Therefore, a new form of dosage with exceptional characteristics like invasomes can be created. Graphical abstract

Từ khóa


Tài liệu tham khảo

Dragicevic N, Maibach H (2018) Combined use of nanocarriers and physical methods for percutaneous penetration enhancement. Adv Drug Deliv Rev 127:58–84

Lakshmi P, Kalpana B, Prasanthi D (2013) Invasomes-novel vesicular carriers for enhanced skin permeation. Sys Rev Pharm 4:26

Brown MB, Martin GP, Jones SA, Akomeah FK (2006) Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 13:175–187

Bouwstra J, Honeywell-Nguyen P (2002) Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 54:S41–S55

Elias PM (1983) Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 80(1):44 s–49 s

Bouwstra J, Dubbelaar F, Gooris G, Ponec M (2000) The lipid organisation in the skin barrier. Acta Derma Venereol 208:23–30

Cross S, Roberts M (2004) Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development? Curr Drug Deliv 1:81–92

Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M (2003) Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 42:1–36

Zhou X, Hao Y, Yuan L, Pradhan S, Shrestha K, Pradhan O, Liu H, Li W (2018) Nano-formulations for transdermal drug delivery: a review. Chin Chem Lett 29:1713–1724

Chauhan P, Tyagi BK (2018) Herbal novel drug delivery systems and transfersomes. J Drug Deliv Ther 8:162–168

Karimi N, Ghanbarzadeh B, Hamishehkar H, Keyvani F, Pezeshki A, Gholian MM (2015) Phytosome and liposome: The beneficial encapsulation systems in drug delivery and food application. Appl Food Biotechnol 2(3):17–27

Dragicevic N, Verma DD, Fahr A (2016). Invasomes: Vesicles for enhanced skin delivery of drugs. In: Dragicevic N., Maibach H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg, pp 77–92. https://doi.org/10.1007/978-3-662-47862-2_5.

Prasanthi D, Lakshmi P (2012) Vesicles-mechanism of transdermal permeation: a review. Asian J Pharm Clin Res 5:18–25

Akhtar N (2014) Vesicles: a recently developed novel carrier for enhanced topical drug delivery. Curr. Drug Deliv 11:87–97

Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A (2009) Development of different temoporfin-loaded invasomes—novel nanocarriers of temoporfin: Characterization, stability and in vitro skin penetration studies. Colloids Surf B: Biointerfaces 70:198–206

Ashtikar M, Nagarsekar K, Fahr A (2016) Transdermal delivery from liposomal formulations–Evolution of the technology over the last three decades. J Control Release 242:126–140

Katare OP, Raza K, Singh B, Dogra S (2010) Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. Indian J Dermatol Venereol Leprol 76(6):612–621

Nava-Arzaluz MG, Piñón-Segundo E, Ganem-Rondero A (2019). Lipid nanocarriers as skin drug delivery systems. Nanopart Pharmacother: William Andrew Publishing, pp 311–390 Elsevier. https://doi.org/10.1016/B978-0-12-816504-1.00007-7.

Milewski M, Brogden NK, Stinchcomb AL (2010) Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opin Drug Deliv 7:617–629

Moradi L, Javanmardi S, Abolmaali S, Mohammadi Samani S (2019) Passive enhancement of transdermal drug delivery: Lipid-based colloidal carriers as an emerging pharmaceutical technology platform. Trends Pharmacol Sci 5:25–40

Ashtikar M, Langelüddecke L, Fahr A, Deckert V (2017) Tip-enhanced Raman scattering for tracking of invasomes in the stratum corneum. Biochimica et Biophysica Acta (BBA)-General Subjects 1861(11):2630–2639

Romero EL, Morilla MJ (2015) Ultradeformable phospholipid vesicles as a drug delivery system: a review. Res Reports Transderm Drug Deliv 2015(4):55–69

Bommannan D, Potts RO, Guy RH (1991) Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J Control Release 16:299–304

Dragicevic-Curic N, Friedrich M, Petersen S, Scheglmann D, Douroumis D, Plass W, Fahr A (2011) Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry. Int J Pharm 412:85–94

Shah SM, Ashtikar M, Jain AS, Makhija DT, Nikam Y, Gude R, Steiniger F, Jagtap AA, Nagarsenker MS, Fahr A (2015) LeciPlex, invasomes, and liposomes: A skin penetration study. Int J Pharm 490(1-2):391–403

Qadri GR, Ahad A, Aqil M, Imam SS, Ali A (2017) Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study. Artif Cell Nanomed B 45:139–145

Dwivedi M, Sharma V, Pathak K (2017) Pilosebaceous targeting by isotretenoin-loaded invasomal gel for the treatment of eosinophilic pustular folliculitis: optimization, efficacy and cellular analysis. Drug Dev Ind Pharm 43:293–304

Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A (2008) Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies. J Control Release 127:59–69

Neubert RH (2011) Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm 77:1–2

Prasanthi D, K Lakshmi P (2013) Iontophoretic transdermal delivery of finasteride in vesicular invasomal carriers. Pharm Nanotechnol 1:136-150

Akiladevi D, Basak S (2010) Ethosomes—a noninvasive approach for transdermal drug delivery. Int J Curr Pharm Res 2:1–4

Badran M, Kuntsche J, Fahr A (2009) Skin penetration enhancement by a microneedle device (Dermaroller®) in vitro: Dependency on needle size and applied formulation. Eur J Pharm Sci 36:511–523

Dragicevic-Curic N, Gräfe S, Albrecht V, Fahr A (2008) Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study. J Photochem Photobiol B 91:41–50

Vidya K, Lakshmi P (2019) Cytotoxic effect of transdermal invasomal anastrozole gel on MCF-7 breast cancer cell line. J Appl Pharm Sci 9:050–058

Mura S, Manconi M, Sinico C, Valenti D, Fadda AM (2009) Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 380:72–79

El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM (2018) Dapsone-loaded invasomes as a potential treatment of acne: Preparation, characterization, and in vivo skin deposition assay. AAPS PharmSciTech 19:2174–2184

Duangjit S, Nimcharoenwan T, Chomya N, Locharoenrat N, Ngawhirunpat T (2016) Design and development of optimal invasomes for transdermal drug delivery using computer program. Asian J Pharm Sci 11:52–53

Amnuaikit T, Limsuwan T, Khongkow P, Boonme P (2018) Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes. Asian J Pharm Sci 13:472–484

Ahmed OA, Badr-Eldin SM (2019) Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation. Int J Pharm 570:118657

Kamran M, Ahad A, Aqil M, Imam SS, Sultana Y, Ali A (2016) Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: in vitro characterization and in vivo pharmacokinetic assessment. Int J Pharm 505:147–158

Kalpana B, Lakshmi P (2013) Transdermal permeation enhancement of Tolterodine Tartrate through invasomes and iontophoresis. Der Pharm Lett 5:119–126

Chen M, Liu X, Fahr A (2010) Skin delivery of ferulic acid from different vesicular systems. J Biomed Nanotechnol 6:577–585

Lakshmi P, Mounica V, Manoj KY (2014) Prasanthi D (2014) Preparation and evaluation of curcumin invasomes. Int J Drug Deliv 6:113–120

Dragicevic-Curic N, Gräfe S, Gitter B, Fahr A (2010) Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines. J Photochem Photobiol B 101:238–250

Verma P, Pathak K (2012) Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine 8:489–496

Chung G, Oh SB (2013) Eugenol as local anesthetic. Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes, pp 4001–4015

Vaddi H, Ho P, Chan Y, Chan S (2002) Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes. J Control Release 81:121–133

Sinico C, Fadda AM (2009) Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv 6:813–825

Verma D, Verma S, McElwee K, Freyschmidt-Paul P, Hoffman R, Fahr A (2004) Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles. Eur J Dermatol 14:332–338

Al-Lawati H, Aliabadi HM, Makhmalzadeh BS, Lavasanifar A (2018) Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research. Expert Opin Drug Deliv 15:397–418

Nangare S, Jadhav N, Ghagare P, Muthane T (2020) Pharmaceutical applications of electrospinning. Ann Pharm Fr 78(1):1–11

Hosking A-M, Juhasz M, Mesinkovska NA (2019) Complementary and alternative treatments for alopecia: a comprehensive review. Skin appendage disorders. Skin Appendage Disord 5:72–89

Nangare S, Dhananjay B, Mali R, Shitole M (2020) Development of novel freeze-dried mulberry leaves extract-based transfersomal gel. Turk J Pharm Sci. https://doi.org/10.4274/tjps.98624

Shitole M, Dugam S, Tade R, Desai N, Nangare S (2020) Progress in erectile dysfunction therapy through drug delivery system. Thai J Pharm Sci 44:72–81

Al Faraj A, Shaik AS, Al Sayed B (2015) Preferential magnetic targeting of carbon nanotubes to cancer sites: noninvasive tracking using MRI in a murine breast cancer model. Nanomedicine 10:931–948

Liang F, Chen B (2010) A review on biomedical applications of single-walled carbon nanotubes. Curr Med Chem 17:10–24

Mbah CC, Builders PF, Attama AA (2014) Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus. Expert Opin Drug Deliv 11:45–59